News Aiforia Technologies Oyj

Equities

AIFORIA

FI4000507934

Market Closed - Nasdaq Helsinki Other stock markets 11:14:01 2024-05-03 am EDT			After market 03:03:21 pm
3.94 ^EUR	+2.34%		3.995	+1.40%

Apr. 09	Aiforia Technologies Oyj Appoints Richard Haworth to Its Scientific Advisory Board	CI
Mar. 07	Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aiforia Technologies Oyj Appoints Richard Haworth to Its Scientific Advisory Board	Apr. 09	CI
Aiforia Technologies Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 07	CI
Aiforia Technologies Plc Releases Aiforia Studies A Software Module Offerering Ai-Assisted Image Analysis Workflow	Mar. 06	CI
Aiforia Technologies Plc updates its short and mid-term business targets	Jan. 19	AQ
Aiforia Partners with US Nonprofit to Commercialize AI Predicting Colorectal Cancer Recurrence	Jan. 02	MT
Aiforia signs a licensing agreement with the Mayo Clinic for an AI model that improves prediction of colorectal cancer recurrence	Jan. 02	AQ
Aiforia Signs a Licensing Agreement with the Mayo Clinic for an AI Model That Improves Prediction of Colorectal Cancer Recurrence	Jan. 02	CI
Aiforia Technologies Enters Three-year Technology Deal with Italian Hospital	Dec. 27	MT
Aiforia Signs A Deal with an Italian Hospital in Catania	Dec. 27	CI
Aiforia signs a deal with an Italian hospital in Catania	Dec. 27	AQ
Share subscriptions based on stock options 2016A	Dec. 22	AQ
Aiforia Technologies Plc - Managers' Transactions	Dec. 19	AQ
Professor Inti Zlobec joins Aiforia's Scientific Advisory Board	Dec. 08	AQ
Aiforia Technologies Oyj Announces Appointment of Professor Inti Zlobec to Its Scientific Advisory Board	Dec. 08	CI
Aiforia Technologies Plc's financial reporting and Annual General Meeting in financial year 2024	Dec. 04	AQ
Change in Aiforia Technologies Plc's Management Team	Dec. 01	AQ
Aiforia Technologies plc Appoints Panu Kauppila as Chief Product Officer and A Member of the Management Team	Dec. 01	CI
Aiforia's transition to IFRS reporting	Dec. 01	AQ
Aiforia initiates path to secure its first regulatory approval in the United States - application to the FDA anticipated in 2024	23-10-20	AQ
Aiforia Technologies Plc Initiates Path to Secure its First Regulatory Approval in the United States	23-10-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aiforia Technologies Oyj

Equities

AIFORIA

FI4000507934

Summary

Filters